
    
      Participants will receive palivizumab solution for injection at 15 mg/kg by IM injection
      every 30 days for a minimum of 3 and a maximum of 5 injections given during anticipated
      periods of RSV risk in the community; the number of doses will depend on the time of
      enrollment during the RSV season.
    
  